206 related articles for article (PubMed ID: 25296353)
1. Chronic granulomatous disease: why an inflammatory disease?
Roxo-Junior P; Simão HM
Braz J Med Biol Res; 2014 Nov; 47(11):924-8. PubMed ID: 25296353
[TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease.
Battersby AC; Cale AM; Goldblatt D; Gennery AR
J Clin Immunol; 2013 Nov; 33(8):1276-84. PubMed ID: 24078260
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cell features in chronic granulomatous disease.
van de Geer A; Cuadrado E; Slot MC; van Bruggen R; Amsen D; Kuijpers TW
Clin Exp Immunol; 2019 Aug; 197(2):222-229. PubMed ID: 30924925
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and molecular inflammatory alterations in chronic granulomatous disease].
León-Lara X; Rodríguez-D'Cid R; Rioja-Valencia R; Ayala-Alvirde A; Aliaga-Taipe IL; Espinosa-Padilla S; Blancas-Galicia L
Rev Alerg Mex; 2020; 67(4):370-380. PubMed ID: 33631904
[TBL] [Abstract][Full Text] [Related]
5. Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase.
Schäppi MG; Jaquet V; Belli DC; Krause KH
Semin Immunopathol; 2008 Jul; 30(3):255-71. PubMed ID: 18509648
[TBL] [Abstract][Full Text] [Related]
6. Genetics and immunopathology of chronic granulomatous disease.
Stasia MJ; Li XJ
Semin Immunopathol; 2008 Jul; 30(3):209-35. PubMed ID: 18509647
[TBL] [Abstract][Full Text] [Related]
7. The role of reactive oxygen species (ROS) in the effector mechanisms of human antimycobacterial immunity.
Fazal N
Biochem Mol Biol Int; 1997 Oct; 43(2):399-408. PubMed ID: 9350348
[TBL] [Abstract][Full Text] [Related]
8. Residual NADPH oxidase and survival in chronic granulomatous disease.
Kuhns DB; Alvord WG; Heller T; Feld JJ; Pike KM; Marciano BE; Uzel G; DeRavin SS; Priel DA; Soule BP; Zarember KA; Malech HL; Holland SM; Gallin JI
N Engl J Med; 2010 Dec; 363(27):2600-10. PubMed ID: 21190454
[TBL] [Abstract][Full Text] [Related]
9. Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease.
Meissner F; Seger RA; Moshous D; Fischer A; Reichenbach J; Zychlinsky A
Blood; 2010 Sep; 116(9):1570-3. PubMed ID: 20495074
[TBL] [Abstract][Full Text] [Related]
10. Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.
Wolach B; Broides A; Zeeli T; Gavrieli R; de Boer M; van Leeuwen K; Levy J; Roos D
J Clin Immunol; 2011 Aug; 31(4):560-6. PubMed ID: 21604087
[TBL] [Abstract][Full Text] [Related]
11. Chronic granulomatous disease.
Roos D
Br Med Bull; 2016 Jun; 118(1):50-63. PubMed ID: 26983962
[TBL] [Abstract][Full Text] [Related]
12. Impaired macrophage function following bacterial stimulation in chronic granulomatous disease.
Rahman FZ; Hayee B; Chee R; Segal AW; Smith AM
Immunology; 2009 Oct; 128(2):253-9. PubMed ID: 19740382
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature.
Kelkka T; Kienhöfer D; Hoffmann M; Linja M; Wing K; Sareila O; Hultqvist M; Laajala E; Chen Z; Vasconcelos J; Neves E; Guedes M; Marques L; Krönke G; Helminen M; Kainulainen L; Olofsson P; Jalkanen S; Lahesmaa R; Souto-Carneiro MM; Holmdahl R
Antioxid Redox Signal; 2014 Dec; 21(16):2231-45. PubMed ID: 24787605
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory consequences of inherited disorders affecting neutrophil function.
Dinauer MC
Blood; 2019 May; 133(20):2130-2139. PubMed ID: 30898864
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory cytokine response toward fungi but not bacteria in chronic granulomatous disease.
Gazendam RP; van de Geer A; van Hamme JL; Helgers L; Rohr J; Chrabieh M; Picard C; Roos D; van den Berg JM; van den Berg TK; Kuijpers TW
J Allergy Clin Immunol; 2016 Sep; 138(3):928-930.e4. PubMed ID: 27283382
[No Abstract] [Full Text] [Related]
16. Gene therapy for chronic granulomatous disease.
Barese CN; Goebel WS; Dinauer MC
Expert Opin Biol Ther; 2004 Sep; 4(9):1423-34. PubMed ID: 15335310
[TBL] [Abstract][Full Text] [Related]
17. Common Infections and Target Organs Associated with Chronic Granulomatous Disease in Iran.
Mortaz E; Azempour E; Mansouri D; Tabarsi P; Ghazi M; Koenderman L; Roos D; Adcock IM
Int Arch Allergy Immunol; 2019; 179(1):62-73. PubMed ID: 30904913
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox.
Patiño PJ; Rae J; Noack D; Erickson R; Ding J; de Olarte DG; Curnutte JT
Blood; 1999 Oct; 94(7):2505-14. PubMed ID: 10498624
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis.
Hattori H; Subramanian KK; Sakai J; Jia Y; Li Y; Porter TF; Loison F; Sarraj B; Kasorn A; Jo H; Blanchard C; Zirkle D; McDonald D; Pai SY; Serhan CN; Luo HR
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3546-51. PubMed ID: 20142487
[TBL] [Abstract][Full Text] [Related]
20. Oxidative killing of microbes by neutrophils.
Roos D; van Bruggen R; Meischl C
Microbes Infect; 2003 Nov; 5(14):1307-15. PubMed ID: 14613774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
